PIM
KITE

Partner Investment Management’s Kite Pharma, Inc. KITE Stock Holding History

Partner Investment Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-79
Closed -$14K – 103
2017
Q3 		$14K Sell
79
-28,758
-100% -$4.01M 0.01% 83
2017
Q2 		$2.99M Buy
28,837
+15,324
+113% +$1.25M 4.02% 1
2017
Q1 		$1.06M Sell
13,513
-3,150
-19% -$195K 1.29% 28
2016
Q4 		$747K Buy
16,663
+7,941
+91% +$390K 0.99% 34
2016
Q3 		$487K Buy
8,722
+3,662
+72% +$204K 0.72% 53
2016
Q2 		$253K Sell
5,060
-482
-9% -$23.7K 0.41% 64
2016
Q1 		$254K Sell
5,542
-3,885
-41% -$188K 0.41% 61
2015
Q4 		$581K Sell
9,427
-1,929
-17% -$136K 0.95% 37
2015
Q3 		$632K Buy
11,356
+5,898
+108% +$371K 0.96% 38
2015
Q2 		$333K Buy
5,458
+2,175
+66% +$124K 0.47% 61
2015
Q1 		$189K Sell
3,283
-474
-13% -$31.8K 0.28% 73
2014
Q4 		$217K Buy
+3,757
New +$158K 0.09% 74

Partner Investment Management's KITE Position: Q4 2017 in Review

Partner Investment Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 79 shares — an estimated $14K sold.

Partner Investment Management first reported a position in KITE in Q4 2014 and held it in 12 quarters. The position peaked at $2.99M in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Partner Investment Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Partner Investment Management sold 79 Kite Pharma, Inc. shares in Q4 2017, an estimated $14K.
  • Partner Investment Management first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 12 quarters.
  • Partner Investment Management's Kite Pharma, Inc. position peaked at $2.99M in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Partner Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.